Healthcare ❯Pharmaceuticals

Clinical Trials

Drug Development Weight Loss Drugs HIV Prevention Cancer Treatment Semaglutide Candidates GLP-1s Competition Phase 3 Ketamine Weight-Loss Drugs Drug Safety Oncology Treatments Efficacy Studies Mpox Treatment Puberty Blockers Mental Health Diabetes Treatment Neurological Conditions Drug Approval Drug Supply ALS Phase 2 Regulatory Approval Response Rate Drug Effectiveness Phase 3 Trials

Bristol Myers Squibb to Acquire 2seventy Bio in $286 Million Deal

Pfizer Faces Activist Pressure as Ex-Execs Withdraw Support for Starboard

Lenacapavir Injection Shows 96% Efficacy in Preventing HIV

New Studies Confirm Safety of Semaglutide for Mental Health

New Non-Hormonal Drug Shows Promise for Menopausal Hot Flashes

Roche's New Weight Loss Pill Shakes Up Pharmaceutical Market

Ketamine Shows Promise for Treatment-Resistant Depression in Clinical Trials

Alnylam's Heart Drug Shows Promising Phase-3 Results, Boosting Stock

Zealand Pharma's Petrelintide Shows Promising Results in Early Weight Loss Trial

Gilead's Lenacapavir Shows 100% Efficacy in HIV Prevention Trial

China's Weight-Loss Drug Market Faces Surge in Demand and Rising Competition

Wegovy Shows Promising Results in Heart Failure and Diabetes Treatment

Viking Therapeutics' Weight Loss Drug Shows Promise in Early Trial

Wegovy Approved for Heart Health, Faces Insurance Coverage Challenges

ALS Drug Relyvrio Fails Key Clinical Trial, May Be Pulled from Market